A case report of heart failure after therapy with ustekinumab

Psoriasis is a chronic immune disorder that affects 2–3% of the US population. Ustekinumab, a monoclonal antibody against IL-23/12, has shown great efficacy in treating psoriasis. Here we present a rare finding of a patient with plaque-type psoriasis who was diagnosed with congestive heart failure a...

Full description

Bibliographic Details
Main Authors: Kourosh Beroukhim, Melissa Danesh, Catherine Nguyen, John Koo, Argentina Leon
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-07-01
Series:Journal of Dermatology and Dermatologic Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352241015000249